Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

March 31, 2013

Conditions
Alzheimer's Disease
Interventions
DRUG

Experimental Bapineuzumab

Bapineuzumab 2 mg, Bapineuzumab 7 mg, Bapineuzumab 20 mg, Placebo

Trial Locations (28)

12210

Janssen AI Investigational Site, Latham

19102

Janssen AI Investigational Site, Philadelphia

27103

Janssen AI Investigational Site, Winston-Salem

30322

Janssen AI Investigational Site, Atlanta

33064

Janssen AI Investigational Site, Deerfield Beach

33143

Janssen AI Investigational Site, South Miami

33166

Janssen AI Investigational Site, Miami Springs

33445

Janssen AI Investigational Site, Delray Beach

33919

Janssen AI Investigational Site, Fort Meyers

40536

Janssen AI Investigational Site, Lexington

45417

Janssen AI Investigational Site, Dayton

46202

Janssen AI Investigational Site, Indianapolis

48334

Janssen AI Investigational Site, Farmington Hills

63104

Janssen AI Investigational Site, St Louis

63141

Janssen AI Investigational Site, Creve Coeur

66160

Janssen AI Investigational Site, Kansas City

85724

Janssen AI Investigational Site, Tucson

85741

Janssen AI Investigational Site, Tucson

90277

Janssen AI Investigational Site, Lomita

90404

Janssen AI Investigational Site, Santa Monica

90631

Janssen AI Investigational Site, La Habra

90806

Janssen AI Investigational Site, Long Beach

91105

Janssen AI Investigational Site, Pasadena

91403

Janssen AI Investigational Site, Sherman Oaks

92056

Janssen AI Investigational Site, Oceanside

97239

Janssen AI Investigational Site, Portland

02360

Janssen AI Investigational Site, Plymouth

02903

Janssen AI Investigational Site, Providence

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

JANSSEN Alzheimer Immunotherapy Research & Development, LLC

INDUSTRY